Evidence quality 4.63/5
Eight-dimension review score against the quality rubric . Each dimension scored 1–5.
- D1 Source grounding
- 3/5
- D2 Source authority
- 5/5
- D3 Arithmetic
- 5/5
- D4 Uncertainty
- 5/5
- D5 Scope
- 5/5
- D6 Prose
- 5/5
- D7 Perception honesty
- 4/5
- D8 Caveat completeness
- 5/5
● your factors — click this risk ▾ to reveal
- Your factors
≈ As likely as
Perceived
Most people over fifty have heard that hip fractures are serious, but the lifetime probability is systematically underestimated. Hip fracture is mentally filed alongside dramatic falls — a frail person slipping on ice — rather than as a near-universal late-life risk with a one-in-seven lifetime probability for women. That up to one in five patients dies within a year of the fracture is rarely part of the public narrative, which tends to treat hip fracture as painful but recoverable.
Source: editorial intuition, not polled
Actual
15 in 100 women aged 50+ will fracture a hip in their remaining lifetime (Europe-29 pooled)
European women aged 50+ (population-weighted across 29 countries — EU27 + UK + Switzerland, Kanis et al. SCOPE 2021)
Show derivation
Rate of 15.0% for women and 5.7% for men from Kanis et al., SCOPE 2021 (Arch Osteoporos 16(1):82), population-weighted across the 29 countries of the EU27 plus the UK and Switzerland. The Europe-29 pooled estimate is used as the headline because no comparable global aggregate with equivalent methodology exists; IOF considers high-income European data broadly representative of HIC populations. Worldwide approximately 1.66 million hip fractures occurred per year as of 1990 (Cooper, Campion & Melton 1992), projected to reach ~6.26 million by 2050. Up to 20% of patients die within a year of a hip fracture (SCOPE 2021), of which about 30% of deaths are causally related to the fracture. The headline figure (0.15) reflects the female rate; male rate is 0.057. Wide regional variance: Scandinavian women ~20%, East Asian women ~7%, reflecting diet, physical activity, and genetic factors. Low bound (0.10) represents East Asian or male populations; high bound (0.20) represents Scandinavian women or those with prior fragility fractures.
Caveats: The 15% figure reflects a lifetime cumulative probability from age 50 for women …
The 15% figure reflects a lifetime cumulative probability from age 50 for women in European high-income countries. It is not a per-year figure. The sex gap (women ~15%, men ~6%) is the most consistent finding in the literature, driven by lower peak bone density in women and greater survival into very old age. Hip fracture mortality is high — up to 20% of patients die within a year, though only about 30% of those deaths are causally related to the fracture — partly because the fracture itself disrupts mobility and triggers downstream complications — infection, thrombosis, deconditioning — rather than because the fracture directly kills. Fall-prevention interventions and osteoporosis screening (USPSTF, FRAX tool) can substantially modify personal risk; this is a risk amenable to clinical action.
How the risk varies
The headline figure averages across very different situations. Here’s how the probability varies by scenario or context:
1 in 5.0 · 20%
Highest rates globally — Scandinavia, UK
1 in 6.7 · 15%
IOF pooled Europe-29 estimate; US rates similar
1 in 14 · 7.0%
Japan, China — roughly half the European rate
1 in 18 · 5.7%
Roughly one-third of women's rate
Bar length and shade rank these scenarios against each other, not against other risks. The exact odds are shown beside each.
Related risks
Other risks on similar themes — for exploring related fears.
Menopause CV risk acceleration
How likely is a woman to develop cardiovascular disease after menopause — and how much does menopause accelerate that risk?
Nursing home admission
What are the odds of spending at least one night in a nursing home during your lifetime?
Pick challenger
Hip fracture sits at an unusual intersection: it is common enough to be near-inevitable for women who live into their eighties, and serious enough to be a leading cause of loss of independent living. Across 29 European countries, the lifetime risk from age 50 reaches roughly 15% for women and 6% for men — a gap that reflects both lower peak bone density in women and longer survival into the ages when fracture risk is highest. Worldwide, approximately 1.6 million hip fractures occur each year, a figure projected to reach six million by 2050 as populations age in Asia and Latin America.
One-year mortality — up to 20% of patients, according to the SCOPE 2021 European scorecard, though only about 30% of those deaths are judged causally related to the fracture — is what transforms hip fracture from a painful but recoverable injury into a major cause of late-life death. The mechanism is often not the fracture itself but the cascade that follows: immobilisation increases the risk of pneumonia, deep-vein thrombosis, and pressure injuries; surgical repair carries perioperative risk in older patients with multiple conditions; and muscle deconditioning from even brief bed rest is difficult to reverse in the ninth decade. The risk of a second fracture within two years roughly doubles the baseline, making first-fracture prevention a high-return clinical intervention.
Regional variation in hip fracture rates is large — perhaps threefold between Northern Europe (highest) and East Asia (lowest) — and not fully explained by diet or activity alone. Genetic factors, differences in hip geometry, and urban-rural differences all contribute. The personal risk is substantially stratifiable using dual-energy X-ray absorptiometry (DEXA) and the FRAX risk calculator, which integrates bone density, age, sex, and clinical risk factors. This is a risk that rewards early assessment, not one where the only response is acceptance.
Related tidbits
Lifetime from age 50, a hip fracture runs about 1 in 7 women; 1 in 18 men. The sex gap is wide, and the event is rarely incidental: in older adults a broken hip often marks a sharp drop in mobility and survival in the year that follows.
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
1/3 sources independently verified verbatim against the cited source
-
[1] Archives of Osteoporosis (Kanis et al.) — SCOPE 2021: a new scorecard for osteoporosis in Europe
SCOPE 2021: a new scorecard for osteoporosis in Europe- Statistic
Average lifetime probability of hip fracture at age 50 in the EU (EU27 + UK + Switzerland): 15.0% in women, 5.7% in men; up to 20% of patients die in the first year following hip fracture- Excerpt
“"The average lifetime probability of hip fracture (weighted for population size) at the age of 50 years in the EU was 5.7% in men and 15.0% in women. Up to 20% of patients die in the first year following hip fracture, mostly as a result of serious underlying medical conditions; it is estimated that approximately 30% of deaths are causally related." ”
- Source data from
- 2021-06-02
- Accessed
- 2026-07-11 · archived copy
- Calculation
- Kanis et al., SCOPE 2021 (Arch Osteoporos 16(1):82, PMC8172408, doi 10.1007/s11657-020-00871-9) reports the population-weighted lifetime probability of hip fracture from age 50 across the 29 countries of the EU27 plus the UK and Switzerland. Native rate: 15 in 100 women from age 50 (direct lifetime probability, verbatim from the paper). Normalized: 0.15 (no conversion needed; figure is already expressed as lifetime probability). Europe-29 pooled estimate used as proxy for global high-income-country rate. Male rate 0.057 treated as supporting figure. Mortality: the paper states up to 20% of hip-fracture patients die within one year (of which ~30% of deaths are causally related to the fracture) — this replaces an earlier "21–30% excess mortality" figure that was not supported by any cited source.
-
[2] Osteoporosis International — Hip fractures in the elderly: a world-wide projection
Hip fractures in the elderly: a world-wide projection- Statistic
Hip fractures worldwide projected to rise from 1.66 million in 1990 to 6.26 million by 2050, with the burden shifting to Asia and Latin America- Excerpt
“"The projections indicate that the number of hip fractures occurring in the world each year will rise from 1.66 million in 1990 to 6.26 million by 2050. While Europe and North America account for about half of all hip fractures among elderly people today, this proportion will fall to around one quarter in 2050, by which time steep increases will be observed throughout Asia and Latin America." ”
- Source data from
- 1992-11-01
- Accessed
- 2026-06-30 · archived copy
- Calculation
- Cooper, Campion & Melton 1992 (Osteoporos Int 2(6):285-9, PMID 1421796) is the original source of the ~1.66M-in-1990 to ~6.26M-by-2050 world-wide hip fracture projection cited in the assumption text. Used here for global burden context, not for the lifetime probability calculation directly. The lifetime probability (0.15) is drawn from the Kanis et al. SCOPE 2021 source above.
-
[3] The Lancet — Epidemiology and outcomes of osteoporotic fractures Verified
Epidemiology and outcomes of osteoporotic fractures- Statistic
Hip fracture frequency is rising 1–3% per year in most regions and varies more widely from region to region than vertebral fracture prevalence- Excerpt
“"Hip fractures, the most serious outcome of osteoporosis, are becoming more frequent than before because the world's population is ageing and because the frequency of hip fractures is increasing by 1-3% per year in most areas of the world. Rates of hip fracture vary more widely from region to region than does the prevalence of vertebral fractures." ”
- Source data from
- 2002-05-18
- Accessed
- 2026-06-30 · archived copy
- Verification
- Excerpt independently re-fetched and confirmed word-for-word against the cited source during our grounding audit.
- Calculation
- Cummings & Melton 2002 Lancet review (Lancet 359(9319):1761-7, PMID 12049882) — foundational epidemiological reference establishing that hip fractures are the most serious osteoporotic outcome, that incidence is rising 1–3% per year, and that rates vary widely by region. Used as a historical anchor to corroborate the regional variation and rising-burden context; the headline lifetime probability (0.15) and the one-year mortality figure (up to 20% of patients) are drawn from the Kanis et al. SCOPE 2021 source above.